|
[1]
|
Hellman, S. and Weichselbaum, R.R. (1995) Oligometastases. Journal of Clinical Oncology, 13, 8-10. [Google Scholar] [CrossRef]
|
|
[2]
|
Broomfield, J.A., Greenspoon, J.N. and Swaminath, A. (2014) Uti-lization of Stereotactic Ablative Radiotherapy in the Management of Oligometastatic Disease. Current Oncology, 21, 115-117. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Jung, J.O., Nienhüser, H., Schleussner, N., et al. (2020) Oli-gometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach. Inter-national Journal of Molecular Sciences, 21, Article No. 951. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Kawaguchi, T. and Nakamura, K. (1986) Analysis of the Lodgement and Extravasation of Tumor Cells in Experimental Models of Hematogenous Metastasis. Cancer and Metastasis Reviews, 5, 77-94. [Google Scholar] [CrossRef]
|
|
[5]
|
Chambers, A.F., Macdonald, I.C., Schmidt, E.E., et al. (1995) Steps in Tumor Metastasis: New Concepts from Intravital Videomicroscopy. Cancer and Metastasis Reviews, 14, 279-301. [Google Scholar] [CrossRef]
|
|
[6]
|
Valastyan, S. and Weinberg, R.A. (2011) Tumor Metastasis: Molecular Insights and Evolving Paradigms. Cell, 147, 275-292. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kyuno, D., Takasawa, A., Kikuchi, S., et al. (2021) Role of Tight Junctions in the Epithelial-to-Mesenchymal Transition of Cancer Cells. Biochimica et Biophysica Acta (BBA)—Biomembranes, 1863, Article ID: 183503. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Zefferino, R., Piccoli, C., Di Gioia, S., et al. (2021) How Cells Communicate with Each Other in the Tumor Microenvironment: Suggestions to Design Novel Therapeutic Strategies in Cancer Disease. International Journal of Molecular Sciences, 22, 2550. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Barghash, A., Golob-Schwarzl, N., Helms, V., et al. (2016) Elevated Expression of the IGF2 mRNA Binding Protein 2 (IGF2BP2/IMP2) Is Linked to Short Survival and Metastasis in Esophageal Adenocarcinoma. Oncotarget, 7, 49743-49750. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Wang, Z., Lin, L., Thomas, D.G., et al. (2015) The Role of Dick-kopf-3 Overexpression in Esophageal Adenocarcinoma. The Journal of Thoracic and Cardiovascular Surgery, 150, 377-385.e2. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Xu, Y., Chen, Y., Wei, L., et al. (2019) Serum Tu-mor-Associated Glycoprotein 72, a Helpful Predictor of Lymph Nodes Invasion in Esophagogastric Junction Adenocar-cinoma. Biochemical and Biophysical Research Communications, 509, 133-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Helminen, O., Huhta, H., Leppänen, J., et al. (2016) Nuclear Lo-calization of Toll-Like Receptor 5 in Barrett’s Esophagus and Esophageal Adenocarcinoma Is Associated with Metastatic Behavior. Virchows Archiv, 469, 465-470. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Castaño-Rodríguez, N., Kaakoush, N.O. and Mitchell, H.M. (2014) Pattern-Recognition Receptors and Gastric Cancer. Frontiers in Immunology, 5, 336. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Yin, X., Feng, C., Han, L., et al. (2018) Diallyl Disulfide Inhibits the Metastasis of Type II Esophageal-Gastric Junction Adenocarcinoma Cells via NF-κB and PI3K/AKT Signaling Pathways in Vitro. Oncology Reports, 39, 784-794. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kalluri, R. and Weinberg, R.A. (2009) The Basics of Epitheli-al-Mesenchymal Transition. Journal of Clinical Investigation, 119, 1420-1428. [Google Scholar] [CrossRef]
|
|
[16]
|
Wang, L., Jin, J.Q., Zhou, Y., et al. (2018) Gli Is Activated and Promotes Epithelial-Mesenchymal Transition in Human Esophageal Adenocarcinoma. Oncotarget, 9, 853-865. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Testa, U., Castelli, G. and Pelosi, E. (2017) Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution. Medicines (Basel), 4, Article No. 67. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Saito, T., Nakanishi, H., Mochizuki, Y., et al. (2015) Preferen-tial HER2 Expression in Liver Metastases and EGFR Expression in Peritoneal Metastases in Patients with Advanced Gastric Cancer. Gastric Cancer, 18, 711-719. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Shi, J., Qu, Y.P. and Hou, P. (2014) Pathogenetic Mechanisms in Gastric Cancer. World Journal of Gastroenterology, 20, 13804-13819. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wu, W.K., Cho, C.H., Lee, C.W., et al. (2010) Dysregulation of Cellular Signaling in Gastric Cancer. Cancer Letters, 295, 144-153. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Ma, H., Wei, Y., Leng, Y., et al. (2014) TGF-β1-Induced Ex-pression of Id-1 Is Associated with Tumor Progression in Gastric Cancer. Medical Oncology, 31, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Lin, Y., Kikuchi, S., Obata, Y., et al. (2006) Serum Levels of Transforming Growth Factor beta1 Are Significantly Correlated with Venous Invasion in Patients with Gastric Cancer. Journal of Gastroenterology and Hepatology, 21, 432-437. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Hacker, U.T., Escalona-Espinosa, L., Consalvo, N., et al. (2016) Evaluation of Angiopoietin-2 as a Biomarker in Gastric Cancer: Results from the Randomised Phase III AVAGAST Trial. British Journal of Cancer, 114, 855-862. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Ferrara, N. (2010) Role of Myeloid Cells in Vascular Endothelial Growth Factor-Independent Tumor Angiogenesis. Current Opinion in Hematology, 17, 219-224. [Google Scholar] [CrossRef]
|
|
[25]
|
Rigamonti, N. and De Palma, M. (2013) A Role for Angi-opoietin-2 in Organ-Specific Metastasis. Cell Reports, 4, 621-623. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Shah, M.A. (2015) Update on Metastatic Gastric and Esophageal Cancers. Journal of Clinical Oncology, 33, 1760-1769. [Google Scholar] [CrossRef]
|
|
[27]
|
Mathenge, E.G., Dean, C.A., Clements, D., et al. (2014) Core Needle Biopsy of Breast Cancer Tumors Increases Distant Metastases in a Mouse Model. Neoplasia, 16, 950-960. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Sawai, H., Funahashi, H., Yamamoto, M., et al. (2003) Interleu-kin-1alpha Enhances Integrin alpha(6)beta(1) Expression and Metastatic Capability of Human Pancreatic Cancer. Oncol-ogy, 65, 167-173. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Bates, R.C. and Mercurio, A.M. (2003) Tumor Necrosis Factor-Alpha Stimulates the Epithelial-to-Mesenchymal Transition of Human Colonic Organoids. Molecular Biology of the Cell, 14, 1790-1800. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Voronov, E., Shouval, D.S., Krelin, Y., et al. (2003) IL-1 Is Re-quired for Tumor Invasiveness and Angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 100, 2645-2650. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Sturm, J.W., Magdeburg, R., Berger, K., et al. (2003) Influence of TNFA on the Formation of Liver Metastases in a Syngenic Mouse Model. International Journal of Cancer, 107, 11-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
O’reilly, M.S., Boehm, T., Shing, Y., et al. (1997) Endostatin: An Endoge-nous Inhibitor of Angiogenesis and Tumor Growth. Cell, 88, 277-285. [Google Scholar] [CrossRef]
|
|
[33]
|
O’reilly, M.S., Holmgren, L., Shing, Y., et al. (1994) Angi-ostatin: A Novel Angiogenesis Inhibitor That Mediates the Suppression of Metastases by a Lewis Lung Carcinoma. Cell, 79, 315-328. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Govaert, K.M., Emmink, B.L., Nijkamp, M.W., et al. (2014) Hypoxia after Liver Surgery Imposes an Aggressive Cancer Stem Cell Phenotype on Residual Tumor Cells. Annals of Surgery, 259, 750-759. [Google Scholar] [CrossRef]
|
|
[35]
|
Alieva, M., Van Rheenen, J. and Broekman, M.L.D. (2018) Potential Impact of Invasive Surgical Procedures on Primary Tumor Growth and Metastasis. Clinical & Experimental Metastasis, 35, 319-331. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Pretzsch, E., Bösch, F., Renz, B., et al. (2021) Operative Trauma and Blood Loss—Impact on Tumor Growth and Recurrence. Shock, 55, 455-464. [Google Scholar] [CrossRef]
|
|
[37]
|
Wang, W., Xiao, J., Shen, S., et al. (2019) Emerging Effect of Anesthesia on Post-Operative Tumor Recurrence and Metastasis. Journal of International Medical Research, 47, 3550-3558. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Peng, Y. and Croce, C.M. (2016) The Role of Mi-croRNAs in Human Cancer. Signal Transduction and Targeted Therapy, 1, Article No. 15004. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Rapado-González, Ó., Álvarez-Castro, A., López-López, R., et al. (2019) Circulating microRNAs as Promising Biomarkers in Colorectal Cancer. Cancers (Basel), 11, 898. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Aceto, N. (2020) Bring along Your Friends: Homotypic and Heter-otypic Circulating Tumor Cell Clustering to Accelerate Metastasis. Biomedical Journal, 43, 18-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Alix-Panabieres, C., Magliocco, A., Cortes-Hernandez, L.E., et al. (2022) Detection of Cancer Metastasis: Past, Present and Future. Clinical & Experimental Metastasis, 39, 21-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Silver, D.A., Pellicer, I., Fair, W.R., et al. (1997) Pros-tate-Specific Membrane Antigen Expression in Normal and Malignant Human Tissues. Clinical Cancer Research, 3, 81-85.
|
|
[43]
|
Barnum, K.J. and Weiss, S.A. (2020) Prognostic and Predictive Biomarkers in Oligometastatic Disease. The Cancer Journal, 26, 100-107. [Google Scholar] [CrossRef]
|
|
[44]
|
Chia, B., Landau, D., Hanna, G., et al. (2019) Thoracic Intervention and Surgery to Cure Lung Cancer: An Overview of Stereotactic Ablative Radio-therapy in Early and Oligometastatic Lung Cancer. Journal of the Royal Society of Medicine, 112, 334-340. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Ridouani, F. and Srimathveeravalli, G. (2019) Percutaneous Im-age-Guided Ablation: From Techniques to Treatments. La Presse Médicale, 48, e219-e231. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Lachance, C. and Campbell, K. (2019) CADTH Rapid Response Reports. Stereotactic Body Radiotherapy for Oligometastatic Cancer: A Review of Clinical Effectiveness and Cost-Effectiveness. Canadian Agency for Drugs and Technologies in Health, Ottawa.
|
|
[47]
|
Khalife, M., Shahid, K., Dabney, R.S., et al. (2019) Stereotactic Body Radiation Therapy and Immunotherapy. Clinical Advances in Hematology and Oncology, 17, 518-523.
|
|
[48]
|
Ko, E.C. and Formenti, S.C. (2019) Radiation Therapy to Enhance Tumor Immuno-therapy: A Novel Application for an Established Modality. International Journal of Radiation Biology, 95, 936-939. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Picchi, S.G., Lassandro, G., Bianco, A., et al. (2020) RFA of Primary and Metastatic Lung Tumors: Long-Term Results. Medical Oncology, 37, Article No. 35. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Yakkala, C., Chiang, C.L., Kandalaft, L., et al. (2019) Cryoabla-tion and Immunotherapy: An Enthralling Synergy to Confront the Tumors. Frontiers in Immunology, 10, Article No. 2283. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Schizas, D., Lazaridis, I.I., Moris, D., et al. (2018) The Role of Surgical Treatment in Isolated Organ Recurrence of Esophageal Cancer—A Systematic Review of the Literature. World Journal of Surgical Oncology, 16, Article No. 55. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Mönig, S., Van Hootegem, S., Chevallay, M., et al. (2018) The Role of Surgery in Advanced Disease for Esophageal and Junctional Cancer. Best Practice & Research Clinical Gastro-enterology, 36-37, 91-96. [Google Scholar] [CrossRef] [PubMed]
|